CClinicalTrials.gg
CompletedNCT04740112Updated Mar 6, 2024

Beta-glucan, Product Claims and Satiety

An interventional study of Foods with beta-glucan from oats and barley in Healthy, sponsored by General Mills. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by General Mills · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This is a digital clinical trial to investigate satiety and consumer preference in responses to three test breakfast bars with varying level of dietary fiber, beta-glucan, and product packages (with or without product claims) in healthy adults.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

General Mills is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy adults 18-70 years.
  • Habitual snack bar consumers (consume bars at least 3 times a week).
  • Body mass index 20-29.9 kg/m² (based on self-reported weight and height).
  • Understand the study procedures.
  • Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
  • Willing to follow study procedures on test days.
  • Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day.
  • Willing to provide informed consent to participate in the study.
  • Willing to maintain confidentiality of the study and test products.

Exclusion criteria

Exclusion Criteria:

  • Pregnant or lactating women, or women who are planning to become pregnant during the study
  • Known food allergies, sensitivity, or intolerance to any food or food ingredients
  • Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification
  • Taking medications that affect appetite, metabolism, or blood pressure
  • Taking supplements with dietary fiber
  • Presence of acute diseases or infection
  • Presence or history of chronic diseases
  • Diagnosed with eating disorders
  • Restraint eaters
  • Lost or gained 5 pounds or more in the past 3 months
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
130 participants (actual)

Study arms

  • Placebo comparator
    Control breakfast bar with low dietary fiber without product claims

    Other: Foods with beta-glucan from oats and barley

  • Experimental
    Test breakfast bar with high dietary fiber without product claims

    Other: Foods with beta-glucan from oats and barley

  • Experimental
    Test breakfast bar with high dietary fiber with product claims

    Other: Foods with beta-glucan from oats and barley

Interventions

  • OtherFoods with beta-glucan from oats and barley

    Breakfast bars made with varying levels of total dietary fiber and beta-glucan, with or without claims on package image

    Also known as: Food

06

What researchers measure

Primary outcomes

  1. Hunger

    Hunger as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 30 minutes after consumption

  2. Hunger

    Hunger as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 60 minutes after consumption

  3. Hunger

    Hunger as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 90 minutes after consumption

  4. Hunger

    Hunger as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 120 minutes after consumption

  5. Hunger

    Hunger as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 180 minutes after consumption

  6. Fullness

    Fullness as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 30 minutes after consumption

  7. Fullness

    Fullness as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 60 minutes after consumption

  8. Fullness

    Fullness as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 90 minutes after consumption

  9. Fullness

    Fullness as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 120 minutes after consumption

  10. Fullness

    Fullness as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 180 minutes after consumption

  11. Desire to eat

    Desire to eat as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 30 minutes after test meal consumption

  12. Desire to eat

    Desire to eat as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 60 minutes after test meal consumption

  13. Desire to eat

    Desire to eat as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 90 minutes after test meal consumption

  14. Desire to eat

    Desire to eat as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 120 minutes after test meal consumption

  15. Desire to eat

    Desire to eat as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 180 minutes after test meal consumption

  16. Prospective consumption

    Prospective consumption as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 30 minutes after test meal consumption

  17. Prospective consumption

    Prospective consumption as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 60 minutes after test meal consumption

  18. Prospective consumption

    Prospective consumption as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 90 minutes after test meal consumption

  19. Prospective consumption

    Prospective consumption as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 120 minutes after test meal consumption

  20. Prospective consumption

    Prospective consumption as measured by visual analog scales in mm using appetite questionnaires

    Time frame: 180 minutes after test meal consumption

Secondary outcomes

  1. Flavor rating

    Subjective ratings on liking of the product flavor using Likert scales

    Time frame: 30 minutes after test meal consumption

  2. Sweetness rating

    Subjective ratings on sweetness of the product using Likert scales

    Time frame: 30 minutes after test meal consumption

  3. Texture rating

    Subjective ratings on liking of the product texture using Likert scales

    Time frame: 30 minutes after test meal consumption

  4. Overall product liking

    Subjective ratings on overall liking of the product using Likert scales

    Time frame: 30 minutes after test meal consumption

  5. Purchase intent

    Likelihood of buying the product using Likert scales

    Time frame: 180 minutes after test meal consumption

07

Study locations

1 site
  • No physical visit to a research facility is required.
    Minneapolis, Minnesota 55427, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04740112
Lead sponsor
General Mills
Responsible party
Sponsor
First posted
Feb 5, 2021
Start date
Jan 28, 2021
Primary completion
Feb 28, 2021
Completion
Jun 30, 2021
Last update
Mar 6, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion